Top Markets
Coin of the day
Voyageur Pharmaceuticals Ltd. Voyageur Pharmaceuticals Ltd.

Voyageur Pharmaceuticals Ltd.

VM
Classifica tra le azioni #29609
Voyageur Pharmaceuticals Ltd. specializes in the creation of mineral-based... Voyageur Pharmaceuticals Ltd. specializes in the creation of mineral-based active pharmaceutical ingredients (APIs). The company aims to produce radiocontrast agents utilizing barium and iodine, along with pharmaceutical products derived from bromine. It possesses complete ownership of three barium sulfate deposits in British Columbia, Canada, two of which are of a quality appropriate for the pharmaceutical barite sector. Furthermore, Voyageur holds stakes in a valuable brine project in Utah, United States, known for its high concentrations of iodine, lithium, and bromine. The company transitioned from its previous name, Voyageur Minerals Ltd., to Voyageur Pharmaceuticals Ltd. in December 2019. Its corporate headquarters are located in Calgary, Canada.
Prezzo delle azioni
$0.12109959
Capitalizzazione di mercato
$21.73M
Variazione (1 giorno)
3.13%
Variazione (1 anno)
8.32%
Paese
CA
Scambia Voyageur Pharmaceuticals Ltd. (VM)

Categoria

EPS per Voyageur Pharmaceuticals Ltd. (VM)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Voyageur Pharmaceuticals Ltd., l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Voyageur Pharmaceuticals Ltd. da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti